Amaero (3DA) investor relations material

Executive summary

• Trailing twelve-month revenue increased 347% year-over-year, reaching $11.8 million (A$ equivalent: A$2.6 million in Q3 FY2026), with both powder and PM-HIP segments contributing to growth and strong Q4 backlog supporting full-year revenue visibility.

• FY2026 revenue guidance reaffirmed at $18–$20 million (A$18–20 million), with all revenue fully contracted and over $18 million already secured.

• Redomiciliation to the U.S. is underway to support defense contract eligibility, future U.S. IPO, and improved access to capital markets, with a new Delaware parent and ASX listing maintained.

• Major distribution and supply agreements secured, including a three-year deal with UPM and a $7.8 million (A$7.8 million) FY2027 titanium contract, underpinning future revenue visibility.

• Strengthened governance with the appointment of Tim Johnson to the board and ongoing PCAOB audit in preparation for a potential U.S. listing.

Financial highlights

• Q3 FY2026 revenue was $2.6 million (A$2.6 million), up 301% year-over-year, with powder and PM-HIP segments contributing A$1.8 million and A$0.7 million, respectively.

• Trailing twelve-month revenue increased 347% year-over-year, driven by powder ramp and secured demand.

• Q4 FY2026 contracted revenue stands at $8.4 million (A$8.4 million), providing strong near-term visibility.

• Cash balance at March 31, 2026, was $38.3 million (A$38.3 million), including $4.9 million (A$4.9 million) restricted, with a pro forma balance of $44.1 million (A$44.1 million) after EXIM Bank reimbursement.

• Gross PP&E plus inventory increased from $41 million to $72 million (A$72.0 million), supporting production scale.

Outlook and guidance

• FY2026 revenue guidance of $18–$20 million (A$18–20 million) is 100% contracted, with $8.4 million (A$8.4 million) secured for Q4.

• Entering FY2027 with strong revenue visibility from long-term agreements, including a $7.8 million (A$7.8 million) titanium supply contract.

• PM-HIP segment expected to outpace overall growth and increase revenue share by FY2028.

• Titanium powder production capacity to double in FY2027 over FY2026.

• Additional capacity commissioning targeted for June 2026, with focus on disciplined execution and capital program completion.